Pharmacokinetic Profile of Rosemary Extract Supplement

CJ CheilJedang

Status: Not yet enrolling

Conditions: Pharmacokinetics

Treatments: Dietary Supplement: Rosemary extract

Study type: Interventional

Funder types: Industry

Identifiers

NCT05931341

CJFNT000001

Details and patient eligibility

About

This study is a clinical trial to observe changes in biomarkers in the blood at pre- and post-supplementation of rosemary extract in healthy adults.

Enrollment: 12 estimated patients

Sex: All

Ages: 25 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects aged between 25 and 55 years
• Non-smoker
• Body Mass Index (BMI) between 20 and 30 kg/m2

Exclusion criteria

• Any history or presence of cardiovascular, pulmonary, gastro-intestinal, hepatic, renal, endocrine, metabolic, hematological, neurologic, psychiatric, systemic or infectious disease

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

12 participants in 3 patient groups

Dosage 1

Experimental group

Treatment:

Dietary Supplement: Rosemary extract

Dosage 2

Experimental group

Treatment:

Dietary Supplement: Rosemary extract

Dosage 3

Experimental group

Treatment:

Dietary Supplement: Rosemary extract